Print overview
June 30, 2017
Bayer Aktiengesellschaft: Bayer expects negative earnings impact from its Brazilian Crop Science business
February 08, 2017
Bayer Aktiengesellschaft: Phase III COMPASS study with Bayer's Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early
November 15, 2016
Bayer Aktiengesellschaft: Bayer to issue mandatory convertible notes
September 14, 2016
Bayer Aktiengesellschaft: Bayer and Monsanto to Create a Global Leader in Agriculture
September 06, 2016
Bayer Aktiengesellschaft: Negotiations regarding Monsanto acquisition advance
« Back
11 - 15 / 26
Next »